Your browser doesn't support javascript.
loading
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort.
Vancappel, Alexis; Dansou, Yecodji; Godin, Ophelia; Haffen, Emmanuel; Yrondi, Antoine; Stephan, Florian; Richieri, Raphaelle Marie; Molière, Fanny; Holtzmann, Jérôme; Horn, Mathilde; Allauze, Etienne; Genty, Jean Baptiste; Bouvard, Alex; Dorey, Jean-Michel; Hennion, Vincent; Camus, Vincent; Fond, Guillaume; Peran, Barbara; Walter, Michel; Anguill, Loic; Scotto D'apolina, Charlotte; Vilà, Estelle; Fredembach, Benjamin; Petrucci, Jean; Rey, Romain; Nguon, Anne Sophie; Etain, Bruno; Carminati, Mathilde; Courtet, Philippe; Vaiva, Guillaume; Llorca, Pierre Michel; Leboyer, Marion; Aouizerate, Bruno; Bennabi, Djamila; El Hage, Wissam.
Afiliação
  • Vancappel A; Fondation FondaMental, 94000 Créteil, France.
  • Dansou Y; CHRU de Tours, UMR 1253, iBrain, Université de Tours, Inserm, 37000 Tours, France.
  • Godin O; EE 1901 Qualipsy, Université de Tours, 37000 Tours, France.
  • Haffen E; Fondation FondaMental, 94000 Créteil, France.
  • Yrondi A; Fondation FondaMental, 94000 Créteil, France.
  • Stephan F; INSERM U955, Équipe de Psychiatrie Translationnelle, Université Paris-Est Créteil, DHU Pe-PSY, Pôle de Psychiatrie des Hôpitaux Universitaires H Mondor, 94000 Créteil, France.
  • Richieri RM; Fondation FondaMental, 94000 Créteil, France.
  • Molière F; Department of Clinical Psychiatry, CIC-1431 INSERM, CHU de Besançon, UR481 Neurosciences and Cognition, University of Franche-Comté, 25000 Besançon, France.
  • Holtzmann J; Fondation FondaMental, 94000 Créteil, France.
  • Horn M; Service de Psychiatrie et de Psychologie Médicale de l'adulte, CHU de Toulouse, Hôpital Purpan, Université Paul Sabatier Toulouse 3, 31062 Toulouse, France.
  • Allauze E; Fondation FondaMental, 94000 Créteil, France.
  • Genty JB; Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale, 29200 Brest, France.
  • Bouvard A; Fondation FondaMental, 94000 Créteil, France.
  • Dorey JM; Equipe Imothep, Institut Fresnel, UMR 7249, Aix-Marseille Université, CNRS, Ecole Centrale Marseille, 13284 Marseille, France.
  • Hennion V; Fondation FondaMental, 94000 Créteil, France.
  • Camus V; Department of Emergency Psychiatry and Post Acute Care, Hôpital Lapeyronie, CHU Montpellier, 34000 Montpellier, France.
  • Fond G; Fondation FondaMental, 94000 Créteil, France.
  • Peran B; Service Hospitalo-Universitaire de Psychiatrie, CHU Grenoble Alpes, University Grenoble Alpes, 38400 Grenoble, France.
  • Walter M; Fondation FondaMental, 94000 Créteil, France.
  • Anguill L; Fondation FondaMental, 94000 Créteil, France.
  • Scotto D'apolina C; Fondation FondaMental, 94000 Créteil, France.
  • Vilà E; Fondation FondaMental, 94000 Créteil, France.
  • Fredembach B; Centre de Référence Régional des Pathologies Anxieuses et de la Dépression, Centre Expert Dépression Résistante, Pôle de Psychiatrie Générale et Universitaire, CH Charles Perrens, 33076 Bordeaux, France.
  • Petrucci J; Laboratoire Nutrition et Neurobiologie Intégrée (UMR INRAE 1286), Université de Bordeaux, 33076 Bordeaux, France.
  • Rey R; Fondation FondaMental, 94000 Créteil, France.
  • Nguon AS; Fondation FondaMental, 94000 Créteil, France.
  • Etain B; INSERM UMR-S 1144 Optimisation Thérapeutique en Neurospsychopharmacologie, Département de Psychiatrie et de Médecine Addictologique, OTeN, Hôpitaux Lariboisière-Fernand Widal, GHU APHP Nord_Université Paris Cité, 75006 Paris, France.
  • Carminati M; Fondation FondaMental, 94000 Créteil, France.
  • Courtet P; CHRU de Tours, UMR 1253, iBrain, Université de Tours, Inserm, 37000 Tours, France.
  • Vaiva G; Fondation FondaMental, 94000 Créteil, France.
  • Llorca PM; Clinical Research Unit, Academic Hospitals of Marseille (APHM), School of Medicine-La Timone Medical Campus, EA 3279, Department of Epidemiology and Health Economics, Aix-Marseille University, 13284 Marseille, France.
  • Leboyer M; Fondation FondaMental, 94000 Créteil, France.
  • Aouizerate B; Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale, 29200 Brest, France.
  • Bennabi D; Fondation FondaMental, 94000 Créteil, France.
  • El Hage W; Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale, 29200 Brest, France.
Brain Sci ; 13(7)2023 Jul 24.
Article em En | MEDLINE | ID: mdl-37509050
ABSTRACT
Previous studies set out profound cognitive impairments in subjects with treatment-resistant depression (TRD). However, little is known about the course of such alterations depending on levels of improvement in those patients followed longitudinally. The main objective of this study was to describe the course of cognitive impairments in responder versus non-responder TRD patients at one-year follow-up. The second aim was to evaluate the predictive aspect of cognitive impairments to treatment resistance in patients suffering from TRD. We included 131 patients from a longitudinal cohort (FACE-DR) of the French Network of Expert TRD Centers. They undertook comprehensive sociodemographic, clinical, global functioning, and neuropsychological testing (TMT, Baddeley task, verbal fluencies, WAIS-4 subtests, D2 and RLRI-16) at baseline (V0) and one-year follow-up (V1). Most patients (n = 83; 63.36%) did not respond (47 women, 49.47 ± 12.64 years old), while one-third of patients responded (n = 48, 30 women, 54.06 ± 12.03 years old). We compared the cognitive performances of participants to average theoretical performances in the general population. In addition, we compared the cognitive performances of patients between V1 and V0 and responder versus non-responder patients at V1. We observed cognitive impairments during the episode and after a therapeutic response. Overall, each of them tended to show an increase in their cognitive scores. Improvement was more prominent in responders at V1 compared to their non-responder counterparts. They experienced a more marked improvement in code, digit span, arithmetic, similarities, and D2 tasks. Patients suffering from TRD have significant cognitive impairments that persist but alleviate after therapeutic response. Cognitive remediation should be proposed after therapeutic response to improve efficiency and increase the daily functioning.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Brain Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Brain Sci Ano de publicação: 2023 Tipo de documento: Article